Medicine guide
abnobaVISCUM Fraxini D10
As listed in the register: abnobaVISCUM Fraxini D10, anthroposophisches Arzneimittel
·
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Viscum album fraxini ex herba recente col. D10 (HAB 32)
- Made by
- Future Health Pharma GmbH
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Gemäss der anthroposophischen Menschen- und Naturerkenntnis zur Zusatzbehandlung bei malignen Erkrankungen bei Erwachsenen
From the official label · 2026-09-30 · Swissmedic
Details
| Made by | Future Health Pharma GmbH |
|---|---|
| Active substance | Viscum album fraxini ex herba recente col. D10 (HAB 32) |
| Used in | Cancer treatments and immune-system medicines |
| Classification | L01CX · Cancer treatments and immune-system medicines |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | abnobaVISCUM Fraxini D10, anthroposophisches Arzneimittel |
| Packs | 8 à 1ml Ampulle(n) |
| Zulassungsnummer | 68315 |
| Dosisstärke | 6 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.